PHA
Showing 1 - 25 of 230
Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial (PHA-022121 low dose, PHA-022121 medium
Recruiting
- Hereditary Angioedema
- +11 more
- PHA-022121 low dose
- +3 more
-
Birmingham, Alabama
- +7 more
Dec 5, 2022
Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial in Worldwide (PHA-022121, Placebo)
Recruiting
- Hereditary Angioedema
- +9 more
- PHA-022121
- Placebo
-
Birmingham, Alabama
- +21 more
Aug 11, 2022
Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial in Worldwide (PHA-022121, Placebo)
Active, not recruiting
- Hereditary Angioedema
- +9 more
- PHA-022121
- Placebo
-
Birmingham, Alabama
- +35 more
Aug 23, 2022
Hepatocellular Carcinoma Trial in Greece, Israel, Italy (Milciclib maleate)
Completed
- Hepatocellular Carcinoma
- Milciclib maleate
-
Athens, Greece
- +13 more
Oct 11, 2021
Primary Hyperaldosteronism, Hypertensive Disorder of Pregnancy Trial (Aldosterone/Renin Ratio)
Not yet recruiting
- Primary Hyperaldosteronism
- Hypertensive Disorder of Pregnancy
- Aldosterone/Renin Ratio
- (no location specified)
Dec 1, 2022
Irritable Bowel Syndrome Trial in Brussel (Bio-electrical impedance analysis)
Recruiting
- Irritable Bowel Syndrome
- Bio-electrical impedance analysis
-
Brussel, Brussels, BelgiumUZ Brussel
Feb 15, 2023
Phase Angle and Chronic Intestinal Inflammatory Diseases
Recruiting
- Inflammatory Bowel Diseases
- +3 more
-
Bari, BA, ItalyMichele Barone
May 17, 2022
Hypovitaminosis D and "Metabolic" Inflammatory Status in Obesity
Completed
- Hypovitaminosis D
- Obesity
- Vitamin D Plasma Level
- +5 more
-
Trieste, ItalySilvia Palmisano
Nov 3, 2023
(MUE) for Continuous Heparin Infusions in Hospitalized Patients
Completed
- Unfractionated Heparin
-
Dallas, TexasMethodist Richardson Medical Center
Oct 17, 2023
HIV Trial in Durban (Gender-Enhanced -- Masibambane, Individually accessed)
Active, not recruiting
- HIV Infections
- Gender-Enhanced -- Masibambane
- Individually accessed
-
Durban, KwaZulu-Natal, South AfricaSouth African Medical Research Council
Jun 28, 2022
Phage Safety Cohort Study
Recruiting
- Prosthetic Joint Infection
- Severe Infection
- Adverse event after injection of phages
-
Lyon, FranceHospices Civils de Lyon
May 20, 2022
Severe Acute Malnutrition Trial (ready-to-use therapeutic food (RUTF), Amoxicillin)
Not yet recruiting
- Severe Acute Malnutrition
- ready-to-use therapeutic food (RUTF)
- Amoxicillin
- (no location specified)
Sep 24, 2023
Moderate Acute Malnutrition Trial (ready-to-use supplementary food (RUSF), ready-to-use therapeutic food (RUTF), Amoxicillin)
Not yet recruiting
- Moderate Acute Malnutrition
- ready-to-use supplementary food (RUSF)
- +2 more
- (no location specified)
Sep 20, 2023
Implication of 5-HT7 Receptor in Inflammatory Mechanisms in
Not yet recruiting
- Healthy
- Multiple Sclerosis
- Blood sample
-
Orléans, FranceCHR Orléans
Feb 16, 2023
Pulmonary Hypertension (PAH) in Patients With Thalassemia
Completed
- Thalassemia Major
- +2 more
- Physician standard-of-care according to ESC/ERS Guidelines
-
Orbassano, Turin, Italy
- +7 more
Aug 3, 2022
Cross-sectional Characterization of Idiopathic Bronchiectasis
Completed
- Infection
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 7, 2023
Strategies for Stenotrophomonas Maltophilia Pneumonia
Recruiting
- Stenotrophomonas Maltophilia Infection
-
Dallas, TexasMethodist Dallas Medical Center
Oct 30, 2023
Short Versus Long Duration of Therapy for Streptococcus
Recruiting
- Streptococcus Pneumoniae
- pneumoniae bacteremia therapy
-
Dallas, TexasMethodist Dallas Medical Center
Oct 17, 2023
Pharmacokinetics Trial in Klamath Falls (1 gram of a protein hydrolysate, 2 grams of a protein hydrolysate, 4 grams of a protein
Recruiting
- Pharmacokinetics
- 1 gram of a protein hydrolysate
- +3 more
-
Klamath Falls, OregonGitte Jensen
Jun 7, 2022
Malignant Thymoma Trial in Washington, Bethesda, Milano (Milciclib Maleate)
Terminated
- Malignant Thymoma
- Milciclib Maleate
-
Washington, District of Columbia
- +2 more
Jan 22, 2019
4-Factor PCC in DOAC-associated Intracranial Hemorrhage
Recruiting
- Intracranial Hemorrhage
- Use of fixed-dosed 4F-PCC
-
Dallas, TexasMethodist Dallas Medical Center
Oct 17, 2023
Don't Treat Ghosts Anti-MRSA Antibiotics in Osteomyelitis
Recruiting
- Osteomyelitis
- Anti-MRSA therapy
-
Dallas, TexasMethodist Dallas Medical Center
Oct 17, 2023
Healthy Trial (healthy volunteers blood sampling)
Not yet recruiting
- Healthy
- healthy volunteers blood sampling
- (no location specified)
Aug 29, 2023